Table 1.
Summary of number patients and studies
| Study | Total Pt | Family Hx | Young | Control | BRCA1 | BRCA2 |
|---|---|---|---|---|---|---|
| SUB-SAHARAN AFRICA | ||||||
| Yawitch | 206 | 11 | 0 | 0 | 00 | 0 |
| Gao | 70 | 1 | 70 | 0 | 2 | 1 |
| Fackenthal | 39 | 1 | 39 | 74 | 1 | 0 |
| Zhang B | 365 | UNSELECTED | 177 | 1 | ||
| Masri | 20 | 4 | 1 | |||
| Awadelkarim | 35 | (1Male) | 34 | 0 | 2 | 3 |
| Zhang J | 352 | |||||
| Stoppa Lyonnet | NI | 1 | 1 | |||
| Van der Merwe | 16 | 16 | ||||
| TOTAL | 752 | |||||
| NORTH AFRICA | ||||||
| Balci | 33 | 33 (3 Male) | 0 | 0 | 0 | 0 |
| Ozdag | 50(10 Male) | 13 | 27 | 0 | ||
| Yazici | 105 | 53 | 52 | 0 | 7 | 2 |
| Urhammer | 64 | 13 | 51 | |||
| Troudi | 36 | 36 | ||||
| Cherbal | 86 | |||||
| Mahfoudh et al. (2011) | 24 | 4 | ||||
| TOTAL | 398 | |||||
| GRAND TOTAL | 1150 | |||||